Cargando…
Advancements of Common Gamma-Chain Family Cytokines in Cancer Immunotherapy
The approval of immunotherapies such as checkpoint inhibitors (CPIs), adoptive cell therapies and cancer vaccines has revolutionized the way cancer treatment is approached. While immunotherapies have improved clinical outcome in a variety of tumor types, some cancers have proven harder to combat usi...
Autores principales: | Wolfarth, Alexandra A., Dhar, Swati, Goon, Jack B., Ezeanya, Ugonna I., Ferrando-Martínez, Sara, Lee, Byung Ha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901704/ https://www.ncbi.nlm.nih.gov/pubmed/35291658 http://dx.doi.org/10.4110/in.2022.22.e5 |
Ejemplares similares
-
The Role of Interleukin-7 in the Formation of Tertiary Lymphoid Structures and Their Prognostic Value in Gastrointestinal Cancers
por: Ware, Michael Brandon, et al.
Publicado: (2022) -
Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines
por: Dwyer, Connor J., et al.
Publicado: (2019) -
Role of Common-Gamma Chain Cytokines in NK Cell Development and Function: Perspectives for Immunotherapy
por: Meazza, Raffaella, et al.
Publicado: (2011) -
The anti-inflammatory potential of cefazolin as common gamma chain cytokine inhibitor
por: Żyżyńska-Granica, Barbara, et al.
Publicado: (2020) -
Modeling cell-specific dynamics and regulation of the common gamma chain cytokines
por: Farhat, Ali M., et al.
Publicado: (2021)